A carregar...
How should we treat vascular and fibrotic lung disease in scleroderma?
Recent randomized trials suggest that evidence-based algorithms for systemic sclerosis can be developed to identify patients at risk for lung disease, follow lung disease progression, and modify disease with therapies of proven benefit. Recognition of disease subsets allows physicians to integrate p...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medicine Reports Ltd
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948303/ https://ncbi.nlm.nih.gov/pubmed/20948723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/M1-57 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|